
Similar Posts

Hearing aid use could help people extend their lives, USC study finds
Wearing hearing aids could increase life span, a new study has found. Research by the Keck School of Medicine at the University of Southern California found that people who wear hearing aids regularly had a 24% lower risk of mortality. The study, published in The Lancet Healthy Longevity earlier this month, evaluated the history of…

The 4 New Year’s Resolutions Cardiologists Always Make
It’s the season when many people set New Year’s resolutions for the year ahead, and these goals are often related to physical health. Experts say there’s one big area that many people should focus on when it comes to their well-being: cardiovascular health. “Cardiovascular disease is the number one cause of death in America,” said…

Teen’s death in Wisconsin sawmill highlights “21st century problem” across the U.S.
Like most workplace accidents, the tragedy that took place at a Wisconsin sawmill in June didn’t have to happen. In fact, Michael Schuls, a high school student who had turned 16 just weeks before his death, should never have been trying to unjam a stick stacker machine at Florence Hardwoods in the first place. So…

Asia’s year in review: Who had it good — and who had it bad — in 2023
Curtis S. Chin, a former U.S. ambassador to the Asian Development Bank, is managing director of advisory firm RiverPeak Group. Jose B. Collazo is an analyst focusing on the Indo-Pacific region. Follow them on X at @CurtisSChin and @JoseBCollazo. As 2023 comes to a close, we take a look at the year that was in…

Prescriptions for Eli Lilly’s new weight-loss drug get off to a strong start and confirm bright outlook
The launch of Eli Lilly ‘s weight-loss drug Zepbound — a key pillar of our investment thesis in the pharmaceuticals giant — is going swimmingly in the U.S., Jefferies said Friday. Weekly Zepbound prescriptions totaled 7,700 in the week ended Dec. 8, its fourth on the U.S. market, according to Jefferies, which cited data compiled…